Recombinant Anti-CD28 x Anti-HN Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-CD28 antibody are both extended with the scFv fragment from an anti-HN antibody. This BsAb can retarget T cells to tumor cells. It is designed for the tumor vaccine modification and the research of Tumors therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY